Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Operating Expenses | 2,986 | 7,979 | 4,305 | 13,611 | 8,541 |
| Operating Income | -2,986 | -7,979 | -4,305 | -13,611 | -8,541 |
| Other Income | -607 | -43 | 2,967 | 1,493 | -1,835 |
| Pre-tax Income | -3,593 | -8,022 | -1,339 | -12,118 | -10,377 |
| Net Income Continuous | -3,593 | -8,022 | -1,339 | -12,118 | -10,377 |
| Net Income | $-3,593 | $-8,022 | $-1,339 | $-12,118 | $-10,377 |
| EPS Basic Total Ops | 0.00 | -20.00 | 0.00 | -20.00 | -20.00 |
| EPS Basic Continuous Ops | -4.70 | -10.52 | -1.75 | -17.22 | -17.62 |
| EPS Diluted Total Ops | 0.00 | -20.00 | 0.00 | -20.00 | -20.00 |
| EPS Diluted Continuous Ops | -4.70 | -10.52 | -1.75 | -17.22 | -17.62 |
| EBITDA(a) | $-2,976 | $-7,970 | $-4,296 | $-13,601 | $-8,531 |